ImmuPharma plc (LON:IMM – Get Free Report)’s stock price traded up 7.5% during trading on Monday . The stock traded as high as GBX 1.32 ($0.02) and last traded at GBX 1.32 ($0.02). 1,167,245 shares traded hands during mid-day trading, a decline of 34% from the average session volume of 1,776,601 shares. The stock had previously closed at GBX 1.23 ($0.02).
ImmuPharma Stock Up 1.7 %
The firm has a market cap of £5.15 million, a PE ratio of -123.00 and a beta of 1.53. The business has a 50-day moving average price of GBX 1.71 and a two-hundred day moving average price of GBX 1.84.
About ImmuPharma
ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.
See Also
- Five stocks we like better than ImmuPharma
- 3 REITs to Buy and Hold for the Long Term
- Beyond NVIDIA: Top 5 Semiconductor Stocks to Watch for 2025
- Business Services Stocks Investing
- Netflix Is On Track To Hit $1,000 By Christmas
- Basic Materials Stocks Investing
- UMAC Stock Climbs Amid Trump Jr. Appointment and Meme Stock Hype
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
